Navigation Links
Skin Clinic Doctors Fleece Medicare

Medicare, one of Australia health providers is busy counting its losses.

Accordingly, skin clinics round the country have had their doctors resort to rorting or over servicing, //by prescribing expensive operations and procedures that were not necessary.

The loss in figure s caused by over billing Medicare will be reported today as Medicare's compliance body releases its 'Report to the Professions', which looks at inappropriate practices such as over-servicing and fraud.

Says Colin Bridge, spokesman for Medicare “The concern here is whether or not the treatment that's been provided by the skin cancer clinic is in fact something that's a medical need for the patient, as opposed to what we call screening - where people are taken on and given tests that they may not necessarily need to have.”

Skin clinics will now be closely monitored as there have been reports of several cases in which treatment at skin clinics appears to have been aimed at increasing profit for practitioners rather than what medical peers would regard as being in the best interest of patients.

The report also raises concerns about GPs claiming generous Medicare benefits for extended primary care sessions with older people and Aboriginal patients when all they had done was tick the boxes on a computer-generated form rather than carry out a detailed health assessment.


AN
'"/>




Page: 1

Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. Specialized Clinics For Manipurs AIDS Patients
6. A Novel System For Clinical Banking Of Umbilical Cord Blood
7. Clinical Renal Trails Do Not Have Sufficient Women Participants
8. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
9. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
10. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
11. Cancer Clinical Research in India

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Skin Clinic Doctors Fleece Medicare

(Date:11/21/2009)... Hall, president and chief executive officer of th...he following statement regarding the inclusion of ...annual wellness for Medicare beneficiaries in &quo...uot; that was introduced last night: , ...09 -- Eric J. Hall, president and chief executive ...
(Date:11/20/2009)...0 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals...hareholders will be held on Monday, December 21, 2...roval of two special resolutions. The first specia...of all or substantially all of the assets of NUCRY... asset purchase agreement dated November 10, 2009 ...
(Date:11/20/2009)...s and Congressmen in Competitive Re-election Battl... , Washington, DC (Vocus)...ning for re-election next year in races deemed to ... come to regret voting for House Speaker Nancy Pel...ing Zogby International/ O’Leary Report pol...
(Date:11/20/2009)...November 20 Cardio Vascu...SLMEDICAL.COM , a leading,developer of advanced ca...hat,the company,s Board of Directors has decided t...nd the Far East for its proprietary next-generatio...asty (PCTA) procedures. , Cardio Vascular...
(Date:11/20/2009)...ovember 20 in the Journal of the National Cancer ...es that often appear in news coverage of cancer re...he media and journals to help alleviate the proble...loshin, M.D., M.S., of Center for Medicine and the...y and Clinical Practice in New Hampshire, and Barn...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...re Holdings,Inc. (Nasdaq: LNCR ) today announced ...nd Exchange Commission (the "SEC") a resale shelf ...08 on Form S-3 pursuant to the terms,of a registra...debentures due 2037 - Series A and $275 million,pr...
...on of KV,s Securities until February 15, ... KV Pharmaceutical Company,(NYSE: KVa/KVb) a fully...develops, manufactures, acquires and markets techn...request for a,trading extension through February 1...
...er in Next Generation Health Management ...ec. 28 It is a true win-win,situation. Crown Equi...rove,the health and productivity of its workforce....low health risk category,- an improvement of 12 pe...
...of restricted calorie intake for diabetics wanting...8 (HealthDay News) -- For the first time, the Amer...pport of low-carbohydrate diets for people with di...ractice recommendations. , The recommendations are...
...stCall/ - Transition Therapeutics Inc.,("Transitio...pleased to,announce that Mr. Carl Damiani has been... Since joining Transition in 2003, Mr. Damiani has...ding licensing and intellectual property strategie...
...(NYSE: MYL ),today announced that Mylan Pharmaceu....S. Food and Drug Administration (FDA) for its Abb...e Hydrochloride Tablets (OTC), 5 mg,and 10 mg., C...ng Sept. 30, 2007., This product will be shipped ...
Other Medicine News:Health News:Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement 2Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 2Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 3Health News:Improving Employee Health While Reducing Costs - A Serious Business Strategy 2Health News:Improving Employee Health While Reducing Costs - A Serious Business Strategy 3Health News: Diabetes Group Backs Low-Carb Diets 2Health News:Transition Therapeutics Announces Appointment of Vice-President of Business Development 2
(Date:11/19/2009)...Newswire/ -- As the seasons change, another season...on preparing yourself. ,, Listen to this report...: ,, http://inr.mediaseed.tv/oneClip_C/?feed...nk is a division of The NewsMarket. Registered jo...and photos at http://www.thenewsmarket.com . ,...
(Date:11/19/2009)... 19 Mach 7 Technologies, a globa...age management solutions, and QStar Technologies h...- neutral archive solution through their common US...national leader in providing digital image distrib...try. Under the agreement, Data Distributing will ...
(Date:11/19/2009)...19 Impliant, Inc., a developer of ...pinal fusion surgery, announced today that it has ...as the Vice President of Clinical and Regulatory A...gi-bin/prnh/20080527/NETU060LOGO ) ,, Mr. Rol...rience in the spinal and medical device field to I...
Breaking Medicine Technology:Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3Stories we tell about national trauma reflect our psychological well being 52964 1Stories we tell about national trauma reflect our psychological well being 52964 2Stories we tell about national trauma reflect our psychological well being 52964 3Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 1Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 2Wildfires set to increase 50 percent by 2050 9392 1Wildfires set to increase 50 percent by 2050 9392 2
... - INNOVIVE Pharmaceuticals,Inc. (OTCBB:IVPH) tod... INNO-406, a potent oral dual Bcr-Abl and Lyn-kina...tolerant chronic,myelogenous leukemia, will be pre...arch Annual Meeting. The meeting takes place April...in Los Angeles,California., Information related t...
...n Valopicitabine Combined,with an Investigational ...07 /PRNewswire-FirstCall/ --,Idenix Pharmaceutical... studies of the novel combination of valopicitabin...s(R)) in both treatment-naive,and treatment- exper...n of the hepatitis C virus (HCV). These data, as w...
Other Medicine Technology:Innovive Pharmaceuticals Announces Additional Data Presentations at,American Association for Cancer Research Annual Meeting 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7
OSR Phenytoin Assay
Digoxin II
Emit 2000 (Convenience Pack) Digoxin Assay
Revised Drug Calibrator
Medicine Products: